StockData
Repligen Corp logo

Repligen Corp (RGEN) stock

RGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 7/30133% above fair value
$162.18−0.60 (-0.37%)

Close on Nov 17, 2026Market cap $10.37BP/E –Yield –

Repligen gross margin

Gross margin is gross profit as a percentage of revenue.

Repligen's gross margin for the twelve months ending Sep 30, 2026 was 53.5%. For fiscal 2025 it was 52.3%, against 43.3% the year before. The highest annual figure on record is 80.2% in fiscal 2010.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202552.3%+9.0
FY2024Dec 31, 202443.3%−0.7
FY2023Dec 31, 202344.0%−12.8
FY2022Dec 31, 202256.9%−1.5
FY2021Dec 31, 202158.3%+1.1
FY2020Dec 31, 202057.2%+1.3
FY2019Dec 31, 201955.9%+0.5
FY2018Dec 31, 201855.4%+2.9
FY2017Dec 31, 201752.5%−2.4
FY2016Dec 31, 201654.9%−2.9
FY2015Dec 31, 201557.8%+1.9
FY2014Dec 31, 201455.9%−11.1
FY2013Dec 31, 201367.0%−12.5
FY2011Mar 31, 201179.6%−0.6
FY2010Mar 31, 201080.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202653.0%−0.2
Q2 FY2026Jun 30, 202653.9%+2.9
Q1 FY2026Mar 31, 202655.7%+1.7
Q4 FY2025Dec 31, 202551.2%+28.0
Q3 FY2025Sep 30, 202553.2%+3.2
Q2 FY2025Jun 30, 202551.0%−0.3
Q1 FY2025Mar 31, 202554.0%+3.9
Q4 FY2024Dec 31, 202423.2%−23.9
Q3 FY2024Sep 30, 202450.0%+24.1
Q2 FY2024Jun 30, 202451.3%+1.2
Q1 FY2024Mar 31, 202450.1%−0.4
Q4 FY2023Dec 31, 202347.1%−4.3
Q3 FY2023Sep 30, 202325.9%−31.0
Q2 FY2023Jun 30, 202350.2%−8.3
Q1 FY2023Mar 31, 202350.5%−9.6
Q4 FY2022Dec 31, 202251.4%−4.6
Q3 FY2022Sep 30, 202256.9%−0.7
Q2 FY2022Jun 30, 202258.5%−3.5
Q1 FY2022Mar 31, 202260.1%+1.9
Q4 FY2021Dec 31, 202156.0%+0.3
Q3 FY2021Sep 30, 202157.6%−0.2
Q2 FY2021Jun 30, 202162.0%+4.1
Q1 FY2021Mar 31, 202158.2%+0.2
Q4 FY2020Dec 31, 202055.7%−1.0
Q3 FY2020Sep 30, 202057.9%+3.1
Q2 FY2020Jun 30, 202057.9%+1.3
Q1 FY2020Mar 31, 202058.0%+2.2
Q4 FY2019Dec 31, 201956.6%+2.1
Q3 FY2019Sep 30, 201954.7%−0.5
Q2 FY2019Jun 30, 201956.6%+0.7
Q1 FY2019Mar 31, 201955.7%−0.4
Q4 FY2018Dec 31, 201854.6%+0.6
Q3 FY2018Sep 30, 201855.2%+9.9
Q2 FY2018Jun 30, 201855.8%−1.2
Q1 FY2018Mar 31, 201856.1%+1.9
Q4 FY2017Dec 31, 201754.0%+1.5
Q3 FY2017Sep 30, 201745.4%–
Q2 FY2017Jun 30, 201757.1%–
Q1 FY2017Mar 31, 201754.3%–
Q4 FY2016Dec 31, 201652.5%–

More Repligen figures

See a number that looks wrong?